Chemicals
Compare Stocks
2 / 10Stock Comparison
BAK vs LYB
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
BAK vs LYB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals | Chemicals - Specialty |
| Market Cap | $638M | $23.04B |
| Revenue (TTM) | $73.77B | $22.48B |
| Net Income (TTM) | $-5.24B | $-774M |
| Gross Margin | 4.4% | -19.3% |
| Operating Margin | -2.8% | -0.9% |
| Forward P/E | — | 9.9x |
| Total Debt | $73.72B | $15.96B |
| Cash & Equiv. | $14.99B | $3.45B |
BAK vs LYB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Braskem S.A. (BAK) | 100 | 35.9 | -64.1% |
| LyondellBasell Indu… (LYB) | 100 | 112.1 | +12.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BAK vs LYB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BAK is the clearest fit if your priority is growth exposure.
- Rev growth 9.7%, EPS growth -147.0%, 3Y rev CAGR -9.8%
- 9.7% revenue growth vs LYB's -25.2%
LYB carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.38, yield 7.7%
- 48.6% 10Y total return vs BAK's 1.7%
- Lower volatility, beta 0.38, current ratio 1.77x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.7% revenue growth vs LYB's -25.2% | |
| Quality / Margins | -3.4% margin vs BAK's -7.1% | |
| Stability / Safety | Beta 0.38 vs BAK's 1.95 | |
| Dividends | 7.7% yield, 2-year raise streak, vs BAK's 0.1% | |
| Momentum (1Y) | +37.2% vs BAK's +3.9% | |
| Efficiency (ROA) | -3.0% ROA vs BAK's -5.6%, ROIC -1.1% vs 1.5% |
BAK vs LYB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BAK vs LYB — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — BAK and LYB each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BAK is the larger business by revenue, generating $73.8B annually — 3.3x LYB's $22.5B. Profitability is closely matched — net margins range from -3.4% (LYB) to -7.1% (BAK). On growth, BAK holds the edge at -18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $73.8B | $22.5B |
| EBITDAEarnings before interest/tax | $2.7B | $865M |
| Net IncomeAfter-tax profit | -$5.2B | -$774M |
| Free Cash FlowCash after capex | -$6.1B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +4.4% | -19.3% |
| Operating MarginEBIT ÷ Revenue | -2.8% | -0.9% |
| Net MarginNet income ÷ Revenue | -7.1% | -3.4% |
| FCF MarginFCF ÷ Revenue | -8.2% | +13.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -18.7% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +95.6% | -100.0% |
Valuation Metrics
BAK leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
On an enterprise value basis, BAK's 13.0x EV/EBITDA is more attractive than LYB's 33.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $638M | $23.0B |
| Enterprise ValueMkt cap + debt − cash | $12.5B | $35.5B |
| Trailing P/EPrice ÷ TTM EPS | -0.65x | -30.43x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 9.92x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 12.99x | 33.44x |
| Price / SalesMarket cap ÷ Revenue | 0.04x | 0.76x |
| Price / BookPrice ÷ Book value/share | — | 2.26x |
| Price / FCFMarket cap ÷ FCF | — | 59.99x |
Profitability & Efficiency
Evenly matched — BAK and LYB each lead in 3 of 6 comparable metrics.
Profitability & Efficiency
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | -7.2% |
| ROA (TTM)Return on assets | -5.6% | -3.0% |
| ROICReturn on invested capital | +1.5% | -1.1% |
| ROCEReturn on capital employed | +1.4% | -1.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 |
| Debt / EquityFinancial leverage | — | 1.56x |
| Net DebtTotal debt minus cash | $58.7B | $12.5B |
| Cash & Equiv.Liquid assets | $15.0B | $3.4B |
| Total DebtShort + long-term debt | $73.7B | $16.0B |
| Interest CoverageEBIT ÷ Interest expense | -0.25x | -1.42x |
Total Returns (Dividends Reinvested)
LYB leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LYB five years ago would be worth $8,867 today (with dividends reinvested), compared to $3,845 for BAK. Over the past 12 months, LYB leads with a +37.2% total return vs BAK's +3.9%. The 3-year compound annual growth rate (CAGR) favors LYB at -1.9% vs BAK's -28.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +26.7% | +62.6% |
| 1-Year ReturnPast 12 months | +3.9% | +37.2% |
| 3-Year ReturnCumulative with dividends | -63.3% | -5.5% |
| 5-Year ReturnCumulative with dividends | -61.5% | -11.3% |
| 10-Year ReturnCumulative with dividends | +1.7% | +48.6% |
| CAGR (3Y)Annualised 3-year return | -28.4% | -1.9% |
Risk & Volatility
LYB leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LYB is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than BAK's 1.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LYB currently trades 85.2% from its 52-week high vs BAK's 69.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.95x | 0.38x |
| 52-Week HighHighest price in past year | $5.29 | $83.94 |
| 52-Week LowLowest price in past year | $2.32 | $41.58 |
| % of 52W HighCurrent price vs 52-week peak | +69.9% | +85.2% |
| RSI (14)Momentum oscillator 0–100 | 53.9 | 50.9 |
| Avg Volume (50D)Average daily shares traded | 2.9M | 8.1M |
Analyst Outlook
LYB leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BAK as "Buy" and LYB as "Hold". Consensus price targets imply 2.9% upside for LYB (target: $74) vs -59.5% for BAK (target: $2). LYB is the only dividend payer here at 7.66% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $1.50 | $73.60 |
| # AnalystsCovering analysts | 6 | 39 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +7.7% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.02 | $5.48 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.9% |
LYB leads in 3 of 6 categories (Total Returns, Risk & Volatility). BAK leads in 1 (Valuation Metrics). 2 tied.
BAK vs LYB: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is BAK or LYB a better buy right now?
For growth investors, Braskem S.
A. (BAK) is the stronger pick with 9. 7% revenue growth year-over-year, versus -25. 2% for LyondellBasell Industries N. V. (LYB). Analysts rate Braskem S. A. (BAK) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BAK or LYB?
Over the past 5 years, LyondellBasell Industries N.
V. (LYB) delivered a total return of -11. 3%, compared to -61. 5% for Braskem S. A. (BAK). Over 10 years, the gap is even starker: LYB returned +48. 6% versus BAK's +1. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BAK or LYB?
By beta (market sensitivity over 5 years), LyondellBasell Industries N.
V. (LYB) is the lower-risk stock at 0. 38β versus Braskem S. A. 's 1. 95β — meaning BAK is approximately 410% more volatile than LYB relative to the S&P 500.
04Which is growing faster — BAK or LYB?
By revenue growth (latest reported year), Braskem S.
A. (BAK) is pulling ahead at 9. 7% versus -25. 2% for LyondellBasell Industries N. V. (LYB). On earnings-per-share growth, the picture is similar: Braskem S. A. grew EPS -147. 0% year-over-year, compared to -156. 6% for LyondellBasell Industries N. V.. Over a 3-year CAGR, BAK leads at -9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BAK or LYB?
LyondellBasell Industries N.
V. (LYB) is the more profitable company, earning -2. 5% net margin versus -14. 6% for Braskem S. A. — meaning it keeps -2. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BAK leads at 1. 3% versus -1. 1% for LYB. At the gross margin level — before operating expenses — LYB leads at 9. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is BAK or LYB more undervalued right now?
Analyst consensus price targets imply the most upside for LYB: 2.
9% to $73. 60.
07Which pays a better dividend — BAK or LYB?
In this comparison, LYB (7.
7% yield) pays a dividend. BAK does not pay a meaningful dividend and should not be held primarily for income.
08Is BAK or LYB better for a retirement portfolio?
For long-horizon retirement investors, LyondellBasell Industries N.
V. (LYB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), 7. 7% yield). Braskem S. A. (BAK) carries a higher beta of 1. 95 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LYB: +48. 6%, BAK: +1. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BAK and LYB?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BAK is a small-cap quality compounder stock; LYB is a mid-cap income-oriented stock. LYB pays a dividend while BAK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.